IP Library › Granted Patent US 8,343,979
Granted Patent B2
US 8,343,979 · App. 13/280,749 · Granted Jan 1, 2013

Use of alkanoyl L-carnitine for the treatment of erectile dysfunction

Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,343,979
App. No.
13/280,749
Granted
Jan 1, 2013
Kind
B2
Abstract

Erectile dysfunction is treated with a combination of propionyl L-carnitine in combination with sildenafil, apomorphine prostaglandin El, pentolamine and papaverine.

Claims (1)

1. A method of treating erectile dysfunction, which comprises administering to a patient in need thereof a composition consisting of 0.5 to 4 mg of propionyl L-carnitine and 50 mg of sildenafil.

Assignments (1)
MERGER Recorded Nov 14, 2017
From: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
To: ALFASIGMA S.P.A.
Reel/Frame 044760/0906 →
Priority Claims (1)
IT RM2001A0708 · Dec 4, 2001 · national
Continuity (3)
Continuation 11649796 · Jan 5, 2007
Division 10497498
Related Publication 20120041005A1 · Feb 16, 2012